Over the past decades, advances in understanding pyrimidine metabolism and its inhibitors, such as dihydroorotate dehydrogenase (DHODH) blockers, have revealed their dual role in tumor suppression and immune modulation [7,8]. The gene discussed is DHODH; the disease is neoplasm.